Wuhan Hiteck Biological Pharma Co Ltd Cash Flow Quality Index
Wuhan Hiteck Biological Pharma Co Ltd cash flow quality index. Wuhan Hiteck Biological Pharma Co Ltd (300683) has a Cash Flow Quality Index of 1.89x as of June 2022. Operating cash flow of CN¥21.11 Million exceeds net income of CN¥11.18 Million, indicating high earnings quality where cash backs reported profits. Explore Wuhan Hiteck Biological Pharma Co Ltd (300683) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Wuhan Hiteck Biological Pharma Co Ltd (2013–2021)
Cash flow quality index of Wuhan Hiteck Biological Pharma Co Ltd from 2013 to 2021. Historical Cash Flow Quality Index for Wuhan Hiteck Biological Pharma Co Ltd across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. See Wuhan Hiteck Biological Pharma Co Ltd balance sheet quality to measure how much of total assets are equity-financed.
Wuhan Hiteck Biological Pharma Co Ltd Cash Flow Quality Index by Year (2013–2021)
Wuhan Hiteck Biological Pharma Co Ltd cash flow quality index by year from 2013 to 2021. Year-by-year earnings quality comparison for Wuhan Hiteck Biological Pharma Co Ltd. For the full cash flow conversion analysis, see how efficiently does Wuhan Hiteck Biological Pharma Co Ltd generate cash.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2021 | 0.40x | CN¥12.09 Million | CN¥30.01 Million | ▼ -60.9% |
| 2019 | 1.03x | CN¥63.03 Million | CN¥61.19 Million | ▲ +28.3% |
| 2018 | 0.80x | CN¥73.42 Million | CN¥91.46 Million | ▲ +36.4% |
| 2017 | 0.59x | CN¥83.08 Million | CN¥141.20 Million | ▼ -35.9% |
| 2016 | 0.92x | CN¥143.86 Million | CN¥156.74 Million | ▼ -52.2% |
| 2015 | 1.92x | CN¥159.89 Million | CN¥83.23 Million | ▲ +54.6% |
| 2014 | 1.24x | CN¥135.40 Million | CN¥108.97 Million | ▲ +25.6% |
| 2013 | 0.99x | CN¥76.82 Million | CN¥77.65 Million | — |